| Identification | Back Directory | [Name]
Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]- | [CAS]
1132709-16-0 | [Synonyms]
Bortizomib SR-OH
(1S,2R)-BortezoMib
Bortezomib (1R,2R)Isomer
Bortezomib (1S, 2R)-Isomer
(1S,2R)-Bortezomib Impurity
Bortezomib S,R-Isomer Impurity
Bortezomib impurities (R, S-isomer)
Bortezomib Impurity (1S,2R - Isomer)
Bortezomib impurity 2/(1S,2R)-Bortezomib
N-(2-Pyrazinecarbonyl)-D-phenylalanine-D-leucine boronic anhydride
(S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butylboronic acid
(1s) - 3-methyl-1 - [(2R) - 1-oxo-3-phenyl-2 - [(pyrazinoyl) - amino] propyl] amino] butyl] boric acid
Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]-
(1S,2R) BortezomibQ: What is
(1S,2R) Bortezomib Q: What is the CAS Number of
(1S,2R) Bortezomib Q: What is the storage condition of
(1S,2R) Bortezomib Q: What are the applications of
(1S,2R) Bortezomib | [Molecular Formula]
C19H25BN4O4 | [MDL Number]
MFCD09749895 | [MOL File]
1132709-16-0.mol | [Molecular Weight]
384.24 |
| Hazard Information | Back Directory | [Uses]
(1S,3R)-Bortezomib is an diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway |
|
| Company Name: |
OPULENT PHARMA
|
| Tel: |
+91-9106692785 +91-9106692785 |
| Website: |
www.www.NOWEBSITE |
|